Obermatt

Dong-A Socio

KSC:000640 · KR7000640003
PharmaceuticalsSmall

360

85
EV / EBIT64
Price / Owner Earnings36
Owner Earnings Yield91
Dividend Yield1
Price/Sales95
EV / Gross Profit61
Price/Book83
Return on Capital65
Cash Return on Capital86
Return on Equity78
EBIT Margin58
Gross Profitability58
Cash Conversion86
Accruals70
Owner Earnings Margin83
Sales growth45
Profit Growth55
Long-Term EPS Growth92
Owner Earnings Growth48
Reinvestment100
Price momentum31
Debt load28
Refinancing36
Debt Payback17
Liquidity42
Analyst ratings79
Opinion Changes50
Price Target Upside33
Market mood3
Value Creation10/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Dong-A Socio clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
TypePublic Company
ExchangeKOSE
Employees161
ISINKR7000640003
Last UpdateApr 2, 2026
Themes
ObesityPharmaceutical

Description

Analysis

Quality compounder

Dong-A Socio Holdings Co., Ltd. is a quality compounder: a well-run business trading at a price that reflects what it is worth.

The price is attractive. You pay 3.4× its owner earnings: the cash an owner could take out each year, which is in the historically attractive zone. At today's price, the market is assuming roughly -19% yearly growth; analysts expect 13%. The price, in other words, assumes less than the experts do.

The trajectory is moderate and the balance sheet is stretched. The company scores 10/20 on our value-creation score: creating some value.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
62
2023202420252026

All-time high

75

Jan 2024

All-time low

25

Jan 2023

Average rank

54

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
95
95
93
89
Price/Earnings
77
95
95
78
Price/Book
83
92
80
80
Dividend Yield
1
60
53
40
Value (overall)
70
96
94
75

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Dong-A Socio with its peers
Samsung Pharm
KSC:001360
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Kwangdong Pharmaceutical
KSC:009290
80
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Hanmi Pharmaceutical
KSC:128940
76
CountrySouth Korea
IndustryPharmaceuticals
SizeMedium
Full Stock Analysis →
JW Pharmaceutical
KSC:001060
95
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Aprogen Biologics
KSC:003060
10
CountrySouth Korea
IndustryPharmaceuticals
SizeX-Small
Full Stock Analysis →
Sumitomo Dainippon Pharma
TYO:4506
79
CountryJapan
IndustryPharmaceuticals
SizeLarge
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →